Professional views on priorities for cervical cancer policy in Uganda: a qualitative study

Simple item page
dc.contributor.authorAnumolu, Natalie
dc.contributor.authorJankowksi, Courtney
dc.contributor.authorAnguzu, Ronald
dc.contributor.authorKasasa, Simon
dc.contributor.authorDickson-Gomez, Julia
dc.contributor.authorBanura, Cecily
dc.contributor.authorWeber, Rachel
dc.date.accessioned2023-05-30T16:27:46Z
dc.date.available2023-05-30T16:27:46Z
dc.date.issued2022
dc.description.abstractCervical cancer incidence in Uganda is three-times that of the global average, and is a leading cause of mortality for women. The main cause is human papillomavirus (HPV). Women living with HIV have a greater risk of acquiring HPV and need better cervical cancer care than their HIV-negative counterparts. Although funding and infrastructure exist for HIV control, they are not in place for cervical cancer. We aimed to assess Ugandan health professionals' knowledge of and perspectives regarding cervical cancer among women with HIV to identify perceived barriers and facilitators, and to guide potential interventions to reduce the burden of cervical cancer. We used qualitative interviews to obtain primary data from professionals working in the HIV field in Uganda, identified through purposive and snowball sampling, and through consultation with colleagues at The AIDS Support Organisation (TASO) and Makerere University in Kampala. Inclusion criteria required the respondent to be a provider, researcher, community health worker, or other authority on cervical cancer and HPV and to be conversant in English. Exclusion criteria included being younger than 18 years. Written and verbal informed consent were obtained in accordance with the Medical College of Wisconsin and Makerere University human subjects protection protocols. Virtual, 1 h-long interviews were conducted and recorded. Interviews consisted of open-ended questions exploring perspectives on, knowledge about, and practices surrounding HPV and cervical cancer among women with HIV in Uganda. Institutional review board approval was obtained from TASO, the Uganda National Council for Science and Technology, and Medical College of Wisconsin. Transcripts were analysed and coded via MaxQDA software for common themes; emerging codes were generated from meaningful quotes as used in specific interviewee contexts of facilitators and barriers to HPV vaccination, cervical cancer screening, and treatment.en_US
dc.identifier.citationAnumolu, N., Lechleitner, K., Patel, N., Jankowksi, C., Anguzu, R., Kasasa, S., ... & Beyer, K. (2022). Professional views on priorities for cervical cancer policy in Uganda: a qualitative study. The Lancet Global Health, 10, S16.https://doi.org/10.1016/S2214-109X(22)00145-0en_US
dc.identifier.issn2214-109X
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/8840
dc.language.isoenen_US
dc.publisherThe Lancet Global Healthen_US
dc.subjectCervical cancer policyen_US
dc.subjectHIVen_US
dc.subjectWomenen_US
dc.titleProfessional views on priorities for cervical cancer policy in Uganda: a qualitative studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Professional views on priorities for cervical cancer policy in Uganda a qualitative study.pdf
Size:
65.53 KB
Format:
Adobe Portable Document Format
Description:
Professional views on priorities for cervical cancer policy in Uganda: a qualitative study
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences